Home
Solutions
Expertise
Сontacts
Trust on conducting studies to NEA Clinical
Why Megalek
We will do our best for your study being successful
CLINICAL TRIALS IN GEORGIA
Since the level of medical care in the country is constantly improving, for this reason Georgia becomes more and more attractive for sponsors every year.
Since 2000, the reorganization of the healthcare system has begun in Georgia. Instead of large Soviet clinics, many small, mostly single-profile clinics began to be created.
By 2010, the number of new clinics exceeded 200. Clinical trials have been conducted in Georgia for more than 15 years.
To date, more than 300 international multicenter clinical trials have been conducted in Georgia.

Georgia is also attractive for clinical trials due to a fast and simplified scheme for regulating relations in this area.

They have established themselves as reliable destinations for pharmaceutical and medical device trials.
CLINICAL DEVELOPMENT SOLUTIONS OVERVIEW
CLINICAL TRIALS IN GEORGIA
Since the level of medical care in the country is constantly improving, for this reason Georgia becomes more and more attractive for sponsors every year.
Since 2000, the reorganization of the healthcare system has begun in Georgia. Instead of large Soviet clinics, many small, mostly single-profile clinics began to be created.
By 2010, the number of new clinics exceeded 200. Clinical trials have been conducted in Georgia for more than 15 years.
To date, more than 300 international multicenter clinical trials have been conducted in Georgia.

Georgia is also attractive for clinical trials due to a fast and simplified scheme for regulating relations in this area.

They have established themselves as reliable destinations for pharmaceutical and medical device trials.
ADVANTAGES:
Georgia might not be the first country that comes to mind when considering countries to conduct clinical studies. However, there is plenty of reason to consider Georgia seriously.

  • Clinical research in Georgia offers full compliance with ICH GCP guidelines.
  • Clinical data is generally of high quality and is accepted by both FDA and EMA.
  • Rapid approval process, which takes only two months to initiate
  • Much lower costs of clinical research compared to the United States and Western Europe
  • Wide variety of clinical areas, including heart and brain CNS diseases.
GAGUA Clinic,
Tbilisi
CAUCASUS MEDICAL CENTRE,
Tbilisi